Commons Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $595K | Buy |
117,522
+8,426
| +8% | +$42.6K | 0.45% | 47 |
|
|
2025
Q1 | $577K | Buy |
109,096
+576
| +0.5% | +$3.05K | 0.53% | 42 |
|
|
2024
Q4 | $734K | Sell |
108,520
-7,439
| -6% | -$50.3K | 0.66% | 35 |
|
|
2024
Q3 | $764K | Buy |
115,959
+4,852
| +4% | +$32K | 0.84% | 26 |
|
|
2024
Q2 | $833K | Buy |
+111,107
| New | +$833K | 1% | 23 |
|